ReviewCancers2025

The CXCL1-CXCR2 Axis as a Component of Therapy Resistance, a Source of Side Effects in Cancer Treatment, and a Therapeutic Target.

Jan Korbecki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.